A New Principal Stratum Estimand Investigating the Treatment Effect in Patients Who Would Comply, If Treated With a Specific Treatment

References

• Akacha, M., Bretz, F., Ohlssen, D., Rosenkranz, G., and Schmidli, H. (2017), “Estimands and Their Role in Clinical Trials,” Statistics in Biopharmaceutical Research, 9, 268–271. DOI: 10.1080/19466315.2017.1302358.
   Web of Science ®Google Scholar
• Angrist, J. D., Imbens, G. W., and Rubin, D. B. (1996), “Identification of Causal Effects Using Instrumental Variables,” Journal of the American Statistical Association, 91, 444–455. DOI: 10.1080/01621459.1996.10476902.
   Web of Science ®Google Scholar
• Bornkamp, B., and Bermann, G. (2019), “Estimating the Treatment Effect in a Subgroup Defined by an Early Post-Baseline Biomarker Measurement in Randomized Clinical Trials With Time-To-Event Endpiont,” Statistics in Biopharmaceutical Research, DOI: 10.1080/19466315.2019.1575280.
   Web of Science ®Google Scholar
• Callegari, F., Akacha, M., Quarg, P., Pandhi, S., von Raison, F., and Zuber, E. (2019), “Estimands in a Chronic Pain Trial: Challenges and Opportunities,” Statistics in Biopharmaceutical Research, DOI: 10.1080/19466315.2019.1629997.
   Web of Science ®Google Scholar
• Cole, S. R., and Hernán, M. A. (2008), “Constructing Inverse Probability Weights for Marginal Structural Models,” American Journal of Epidemiology, 168, 656–664. DOI: 10.1093/aje/kwn164.
   PubMed Web of Science ®Google Scholar
• Fan, C., Wei, L., and Koch, G. G. (2019), “Methods for Missing Data Handling in Phase III Clinical Trials with Nonnormal Endpoints and Nonnormal Covariates,” Statistics in Biopharmaceutical Research, DOI: 10.1080/19466315.2018.1518260.
   Google Scholar
• Faraone, S. (2008), “Interpreting Estimates of Treatment Effect: Implications for Managed Care,” Pharmacy and Therapeutics, 33, 700–711.
   Google Scholar
• Frangakis, C. E., and Rubin, D. B. (2002), “Principal Stratification in Causal Inference,” Biometrics, 58, 21–29. DOI: 10.1111/j.0006-341X.2002.00021.x.
   PubMed Web of Science ®Google Scholar
• Gallop, R., Small, D., Lin, J. Y., Elliot, M. R., Joffe, M., and Ten Have, T. R. (2009), “Mediation Analysis With Principal Stratification,” Statistics in Medicine, 28, 1108–1130. DOI: 10.1002/sim.3533.
   PubMed Web of Science ®Google Scholar
• Hernán, M. A., and Robins, J. M. (2019), Causal Inference, Boca Raton, FL: Chapman & Hall/CRC (forthcoming).
   Google Scholar
• Holland, P. W. (1986), “Statistics and Causal Inference,” Journal of the American Statistical Association, 81, 945–960. DOI: 10.1080/01621459.1986.10478354.
   Web of Science ®Google Scholar
• Imbens, G. W. (2004), “Nonparametric Estimation of Average Treatment Effects Under Exogeneity: A Review,” The Review of Economics and Statistics, 86, 4–29. DOI: 10.1162/003465304323023651.
   Web of Science ®Google Scholar
• Imbens, G. W., and Angrist, J. D. (1994), “Identification and Estimation of Local Average Treatment Effects,” Econometrica, 62, 467–475. DOI: 10.2307/2951620.
   Web of Science ®Google Scholar
• International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use (2017), “ICH Harmonised guideline: E9(R1): Estimands and Sensitivity Analysis in Clinical Trials E9(R1),” available at https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/E9-R1EWG_Step2_Guideline_2017_0616.pdf.
   Google Scholar
• Jo, B., and Stuart, E. A. (2009), “On the Use of Propensity Scores in Principal Causal Effect Estimations,” Statistics in Medicine, 28, 2857–2875. DOI: 10.1002/sim.3669.
   PubMed Web of Science ®Google Scholar
• Lou, Y., Jones, M. P., and Sun, W. (2019), “Estimation of Causal Effects in Clinical Endpoint Bioequivalence Studies in the Presence of Intercurrent Events: Noncompliance and Missing Data,” Journal of Biopharmaceutical Statistics, 29, 151–173. DOI: 10.1080/10543406.2018.1489408.
   PubMed Web of Science ®Google Scholar
• Mallinckrodt, C., Molenberghs, G., and Rathmann, S. (2017), “Choosing Estimands in Clinical Trials With Missing Data,” Pharmaceutical Statistics, 16, 29–36. DOI: 10.1002/pst.1765.
   PubMed Web of Science ®Google Scholar
• Marder, S. R., Hakala, M. J., Josiassen, M. K., Zhang, P., Ouyang, J., Weiller, E., Weiss, C., and Hobart, M. (2017), “Brexpiprazole in Patients With Schizophrenia: Overview of Short- and Long-Term Phase 3 Controlled Studies,” Acta Neuropsychiatrica, 29, 278–290. DOI: 10.1017/neu.2016.57.
   PubMed Web of Science ®Google Scholar
• Metz, C. E. (1978), “Basic Principles of ROC Analysis,” Seminars in Nuclear Medicine, 8, 283–298. DOI: 10.1016/S0001-2998(78)80014-2.
   PubMed Web of Science ®Google Scholar
• Permutt, T. (2018), “Effects in Adherent Subjects,” Statistics in Biopharmaceutical Research, 10, 233, DOI: 10.1080/19466315.2018.1458650.
   Web of Science ®Google Scholar
• Permutt, T. (2019a), “Do Covariates Change the Estimand?,” Statistics in Biopharmaceutical Research, DOI: 10.1080/19466315.2019.1647874.
   Web of Science ®Google Scholar
• Permutt, T. (2019b), “Treatment Effects, Comparisons, and Randomization,” Statistics in Biopharmaceutical Research, 2019.1624192. DOI: 10.1080/19466315.
   Web of Science ®Google Scholar
• R Core Team (2018), R: A Language and Environment for Statistical Computing, Vienna, Austria: R Foundation for Statistical Computing, available at https://www.R-project.org/.
   Google Scholar
• Robins, J. M., Hernán, M. A., and Brumback, B. (2000), “Marginal Structural Models and Causal Inference in Epidemiology,” Epidemiology, 11, 550–560. DOI: 10.1097/00001648-200009000-00011.
   PubMed Web of Science ®Google Scholar
• Rubin, D. B. (1974), “Estimating Causal Effects of Treatments in Randomized and Nonrandomized Studies,” Journal of Educational Psychology, 66, 688–701. DOI: 10.1037/h0037350.
   Web of Science ®Google Scholar
• Sjölander, A., Humphreys, K., Vansteelandt, S., Bellocco, R., and Palmgren, J. (2009), “Sensitivity Analysis for Principal Stratum Direct Effects, With an Application to a Study of Physical Activity and Coronary Heart Disease,” Biometrics, 65, 514–520. DOI: 10.1111/j.1541-0420.2008.01108.x.
   PubMed Web of Science ®Google Scholar
• Snowden, J. M., Rose, S., and Mortimer, K. M. (2011), “Implementation of G-Computation on a Simulated Data Set: Demonstration of a Causal Inference Technique,” American Journal of Epidemiology, 173, 731–738. DOI: 10.1093/aje/kwq472.
   PubMed Web of Science ®Google Scholar
• Stuart, E. A., and Jo, B. (2015), “Assessing the Sensitivity of Methods for Estimating Principal Causal Effects,” Statistical Methods in Medical Research, 24, 657–674. DOI: 10.1177/0962280211421840.
   PubMed Web of Science ®Google Scholar
• Toh, S., and Hernán, M. A. (2008), “Causal Inference From Longitudinal Studies With Baseline Randomization,” The International Journal of Biostatistics, 4, 22, DOI: 10.2202/1557-4679.1117.
   Google Scholar
• VanderWeele, T. J. (2011), “Principal Stratification—Uses and Limitations,” The International Journal of Biostatistics, 7, 1–14. DOI: 10.2202/1557-4679.1329.
   Google Scholar
• VanderWeele, T. J., and Vansteelandt, S. (2009), “Conceptional Issues Concerning Mediation, Interventions and Composition,” Statistics and Its Interface, 2, 457–468. DOI: 10.4310/SII.2009.v2.n4.a7.
   Web of Science ®Google Scholar